These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 22343002

  • 21. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.
    Moon M, Hong HS, Nam DW, Baik SH, Song H, Kook SY, Kim YS, Lee J, Mook-Jung I.
    J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161
    [Abstract] [Full Text] [Related]

  • 22. Brain-reactive autoantibodies prevalent in human sera increase intraneuronal amyloid-β(1-42) deposition.
    Nagele RG, Clifford PM, Siu G, Levin EC, Acharya NK, Han M, Kosciuk MC, Venkataraman V, Zavareh S, Zarrabi S, Kinsler K, Thaker NG, Nagele EP, Dash J, Wang HY, Levitas A.
    J Alzheimers Dis; 2011; 25(4):605-22. PubMed ID: 21483091
    [Abstract] [Full Text] [Related]

  • 23. Shifts in oxidation states of cerium oxide nanoparticles detected inside intact hydrated cells and organelles.
    Szymanski CJ, Munusamy P, Mihai C, Xie Y, Hu D, Gilles MK, Tyliszczak T, Thevuthasan S, Baer DR, Orr G.
    Biomaterials; 2015 Sep; 62():147-54. PubMed ID: 26056725
    [Abstract] [Full Text] [Related]

  • 24. Improving endothelialization by the combined application of polyethylene glycol coated cerium oxide nanoparticles and VEGF in electrospun polyurethane scaffolds.
    Dai WW, Guo HF, Qian DH, Qin ZX, Lei Y, Hou XY, Wen C.
    J Mater Chem B; 2017 Feb 07; 5(5):1053-1061. PubMed ID: 32263883
    [Abstract] [Full Text] [Related]

  • 25. Phosphate ester hydrolysis of biologically relevant molecules by cerium oxide nanoparticles.
    Kuchma MH, Komanski CB, Colon J, Teblum A, Masunov AE, Alvarado B, Babu S, Seal S, Summy J, Baker CH.
    Nanomedicine; 2010 Dec 07; 6(6):738-44. PubMed ID: 20553964
    [Abstract] [Full Text] [Related]

  • 26. Both estrogen and raloxifene protect against beta-amyloid-induced neurotoxicity in estrogen receptor alpha-transfected PC12 cells by activation of telomerase activity via Akt cascade.
    Du B, Ohmichi M, Takahashi K, Kawagoe J, Ohshima C, Igarashi H, Mori-Abe A, Saitoh M, Ohta T, Ohishi A, Doshida M, Tezuka N, Takahashi T, Kurachi H.
    J Endocrinol; 2004 Dec 07; 183(3):605-15. PubMed ID: 15590986
    [Abstract] [Full Text] [Related]

  • 27. LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors.
    Luo G, Yu X, Jin C, Yang F, Fu D, Long J, Xu J, Zhan C, Lu W.
    Int J Pharm; 2010 Jan 29; 385(1-2):150-6. PubMed ID: 19825404
    [Abstract] [Full Text] [Related]

  • 28. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization.
    De Felice FG, Vieira MN, Saraiva LM, Figueroa-Villar JD, Garcia-Abreu J, Liu R, Chang L, Klein WL, Ferreira ST.
    FASEB J; 2004 Sep 29; 18(12):1366-72. PubMed ID: 15333579
    [Abstract] [Full Text] [Related]

  • 29. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
    Mohmmad Abdul H, Sultana R, Keller JN, St Clair DK, Markesbery WR, Butterfield DA.
    J Neurochem; 2006 Mar 29; 96(5):1322-35. PubMed ID: 16478525
    [Abstract] [Full Text] [Related]

  • 30. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
    Robert R, Dolezal O, Waddington L, Hattarki MK, Cappai R, Masters CL, Hudson PJ, Wark KL.
    Protein Eng Des Sel; 2009 Mar 29; 22(3):199-208. PubMed ID: 18927231
    [Abstract] [Full Text] [Related]

  • 31. Naringin nanoparticles against neurodegenerative processes: A preliminary work.
    Nday CM, Eleftheriadou D, Jackson G.
    Hell J Nucl Med; 2019 Mar 29; 22 Suppl():32-41. PubMed ID: 30877721
    [Abstract] [Full Text] [Related]

  • 32. Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: preparation, characterization and efficacy in Parkinson's disease.
    Hu K, Shi Y, Jiang W, Han J, Huang S, Jiang X.
    Int J Pharm; 2011 Aug 30; 415(1-2):273-83. PubMed ID: 21651967
    [Abstract] [Full Text] [Related]

  • 33. Proteomic study of amyloid beta (25-35) peptide exposure to neuronal cells: Impact on APE1/Ref-1's protein-protein interaction.
    Mantha AK, Dhiman M, Taglialatela G, Perez-Polo RJ, Mitra S.
    J Neurosci Res; 2012 Jun 30; 90(6):1230-9. PubMed ID: 22488727
    [Abstract] [Full Text] [Related]

  • 34. Dual response of BDNF to sublethal concentrations of beta-amyloid peptides in cultured cortical neurons.
    Aliaga E, Silhol M, Bonneau N, Maurice T, Arancibia S, Tapia-Arancibia L.
    Neurobiol Dis; 2010 Jan 30; 37(1):208-17. PubMed ID: 19822210
    [Abstract] [Full Text] [Related]

  • 35. The change in antioxidant properties of dextran-coated redox active nanoparticles due to synergetic photoreduction-oxidation.
    Barkam S, Das S, Saraf S, McCormack R, Richardson D, Atencio L, Moosavifazel V, Seal S.
    Chemistry; 2015 Sep 01; 21(36):12646-56. PubMed ID: 26190768
    [Abstract] [Full Text] [Related]

  • 36. Protective effects of a chalcone derivative against Aβ-induced oxidative stress and neuronal damage.
    Kim MJ, Lee YH, Kwak J, Na Y, Yoon HG.
    BMB Rep; 2011 Nov 01; 44(11):730-4. PubMed ID: 22118539
    [Abstract] [Full Text] [Related]

  • 37. Further evidence on mitochondrial targeting of β-amyloid and specificity of β-amyloid-induced mitotoxicity in neurons.
    Tillement L, Lecanu L, Papadopoulos V.
    Neurodegener Dis; 2011 Nov 01; 8(5):331-44. PubMed ID: 21311166
    [Abstract] [Full Text] [Related]

  • 38. Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease.
    Lilja AM, Porras O, Storelli E, Nordberg A, Marutle A.
    J Alzheimers Dis; 2011 Nov 01; 23(2):335-47. PubMed ID: 21116052
    [Abstract] [Full Text] [Related]

  • 39. Polymer-Coated Cerium Oxide Nanoparticles as Oxidoreductase-like Catalysts.
    Baldim V, Yadav N, Bia N, Graillot A, Loubat C, Singh S, Karakoti AS, Berret JF.
    ACS Appl Mater Interfaces; 2020 Sep 16; 12(37):42056-42066. PubMed ID: 32812730
    [Abstract] [Full Text] [Related]

  • 40. Cerium oxide nanoparticles inhibit the migration and proliferation of gastric cancer by increasing DHX15 expression.
    Xiao YF, Li JM, Wang SM, Yong X, Tang B, Jie MM, Dong H, Yang XC, Yang SM.
    Int J Nanomedicine; 2016 Sep 16; 11():3023-34. PubMed ID: 27486320
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.